Company Dynamic
-
Mitsubishi Chemical Terminates $300 Million MMA Plant Plan in the U.S.
2025-01-08In a press release dated December 9, 2020, Mitsubishi Chemical Corporation, a subsidiary of the Mitsubishi Chemical Group, announced its intention to build a new MMA monomer plant in Geismar, Louisiana, USA. This plant was to utilize the Group's proprieta
-
Covestro and DB Cargo BTT Partner to Provide Sustainable MDI Transport to Poland
2025-01-08Covestro is working with logistics specialist DB Cargo BTT to transport chemicals to and within Poland in a more efficient and sustainable way.
-
Mitsubishi Chemical Halts Geismar MMA Monomer Plant Project
2025-01-08Mitsubishi Chemical Corporation, a subsidiary of Mitsubishi Chemical Group, announced its decision to abandon plans to build a new methyl methacrylate (MMA) monomer plant in Geismar, Louisiana.
-
U.S. Initiates Anti-Dumping Investigation on Float Glass from China and Malaysia, $14 Million Affected
2025-01-07According to the announcement from the Ministry of Commerce, on January 2, 2025, the U.S. Department of Commerce announced the initiation of anti-dumping and countervailing duty investigations on float glass imported from China and Malaysia. The scope of
-
Eli Lilly’s New Drug Mounjaro Launched on January 2, Approved for Two Indications
2025-01-07The drug is suitable for the following two categories of adult patients: first, those with type 2 diabetes who, despite receiving treatment with metformin and/or sulfonylureas, still have unsatisfactory blood sugar control based on diet control and exerci
-
WuXi AppTec Sells Irish Vaccine Plant for $500 Million
2025-01-07WuXi AppTec Biologics announced on Monday that it has agreed to sell its vaccine plant in Ireland to U.S. pharmaceutical giant Merck & Co. for approximately $500 million. This move comes after the U.S. House of Representatives passed the Biosecure Act, wh
-
Ashland Signs Definitive Agreement to Sell Its Avoca Business to Mane
2025-01-07Ashland Inc. announced that it has signed a definitive agreement to sell its Avoca business to Mane. The transaction is expected to close in the first quarter of 2025, subject to customary closing conditions.
-
Crystal Crop Protection Acquires Ethoxysulfuron Assets from Bayer AG
2025-01-06Agricultural innovation pioneer Crystal Crop Protection Limited announces the acquisition of the active ingredient Ethoxysulfuron from Bayer AG for sale in certain Asian countries.
-
AkzoNobel's Two Factories Awarded Green Factory Title
2025-01-06AkzoNobel recently announced that two of its decorative paint factories—AkzoNobel Paints (Shanghai) Co., Ltd. and AkzoNobel Paints (Guangzhou) Co., Ltd.—have been awarded the title of "National Green Factory." These two factories have been included in the
-
Jinfang Fund Increases Investment in Wantong Special Plastics by 500 Million
2025-01-06The premium part of the subscription amount paid by Jinfang Fund, amounting to 48,083,556.69 CNY, has been included in the capital reserve of Wantong Special Plastics. Wantong Special Plastics has completed the change of registered capital and related bus
-
Novartis $3,500 Kickback Case Resumes
2025-01-06The U.S. Court of Appeals for the Second Circuit has reinstated the lawsuit against Novartis. The plaintiff is Steven Camburn, a former sales representative for Novartis, who alleges that the company illegally paid kickbacks to doctors to promote its mult
-
Evonik Launches Natural Products CapilAcid Conditioner and Oleobiota Sebum Regulator
2025-01-06Evonik has expanded its portfolio of natural active ingredients with two new botanical ingredients, CapilAcid for hair care and Oleobiota for sebum control.
-
China's State Power Investment Corporation will build the largest alumina processing plant in Guinea in 2025
2025-01-06China's State Power Investment Corporation will begin construction of Guinea's largest alumina processing plant in 2025. The plant will be completed by the end of 2027 and produce 1.2 million tons of alumina per year.
-
Yuekang Pharmaceutical: One Drug, Dual Prices, 7 Yuan Price Difference
2025-01-03On December 30, 2024, Yuekang Pharmaceutical issued a statement responding to the recent report from the National Medical Insurance Bureau regarding the "one drug, dual price" incident concerning ginkgo leaf extract injection. The company explicitly state
-
GSK's New Drug Depemokimab: One Injection Every Six Months for Asthma
2025-01-02According to information from the CDE website, GlaxoSmithKline (GSK) has submitted a marketing application for depemokimab in China. Considering the latest progress in clinical trials, the expected indication for this drug is severe eosinophilic asthma (S
-
Merck's New Drug Miraculously Helps 323 Patients with Lung Disease
2025-01-02The UK Medicines and Healthcare products Regulatory Agency (MHRA) announced on Tuesday the approval of a new drug developed by Merck for the treatment of a rare lung disease. This approval further solidifies the pharmaceutical company’s success in the pot
-
Saks Announces Leadership Appointments as Neiman Marcus Acquisition Completes
2025-01-02Saks Global has announced that it has completed its acquisition of Neiman Marcus Group for a total enterprise value of $2.7 billion. Saks now includes Neiman Marcus, Bergdorf Goodman, Saks Fifth Avenue and Saks OFF 5TH.
-
Neste Launches Co-Processed Renewable Feedstock for Polymer and Chemicals Industries
2025-01-02Neste has expanded its product range for the polymer and chemicals industries with the launch of co-processed renewable feedstocks under its well-known brand Neste RE.
-
Dow Chemical Announces Increase in North American Glycol Ether Prices Starting January 6, 2025
2025-01-02The North American glycol ether market continues to show a bullish trend as the year ends. Throughout December, glycol ether prices continued to rise, reflecting strong demand across industries.
-
Sanofi Submits Market Authorization Application for BTK Inhibitor Rilzabrutinib
2024-12-31According to information published on the CDE (Center for Drug Evaluation) website on December 30, Sanofi’s market authorization application for its BTK inhibitor Rilzabrutinib has been officially accepted. Sanofi has conducted several clinical trials in
Hot News
-
Muriatic Acid vs Hydrochloric Acid: What's the Difference?
-
Is pyrethrin and permethrin the same-What are the key differences
-
BASF announced that due to force majeure, this product has ceased supply!
-
HFC-134a vs R-134a: Key Differences and Applications
-
Acetone vs Alcohol: Key Differences, Uses, and Safety Compared
-
What Is The Difference Between Washing Soda And Soda Ash
-
Lysinate Glycinate vs Glycinate: Key Differences and Benefits
-
Polypropylene vs Polycarbonate: What Is the Difference?
-
What is the Difference Between NaCl and NaCl2?
-
The merger and reorganization of ChemChina and Sinochem is in progress